Literature DB >> 15486044

Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells.

Jimin Xu1, Marco Capezzone, Xiao Xu, Jerome M Hershman.   

Abstract

We previously demonstrated that the human nicotinamide N-methytransferase (NNMT) gene was highly expressed in many papillary thyroid cancers and cell lines. The expression in other papillary and follicular cancers or cell lines and normal thyroid cells was low or undetectable. To gain an understanding of the molecular mechanism of this cell-specific expression, the NNMT promoter was cloned and studied by luciferase reporter gene assay. The promoter construct was expressed highly in papillary cancer cell lines, including those with higher (e.g. BHP 2-7) and lower (e.g. BHP 14-9) NNMT gene expression, and expressed weakly in follicular thyroid cancer cell lines. Further study with 5'-deletion promoter construct suggested that the NNMT promoter was regulated differently in BHP 2-7 and BHP 14-9 cells. In BHP 2-7 cells, promoter activity was dependent on an upstream sequence. In BHP 14-9 cells, sequence in the basal promoter region contributed notably to the overall promoter activity. RT-PCR or Western blot analysis indicated that hepatocyte nuclear factor-1beta (HNF-1beta) was expressed in only papillary cancer cell lines with high NNMT gene expression. HNF-1beta was not expressed or expressed very weakly in other papillary, follicular, and Hurthle cancer cell lines and primary cultures of normal thyroid cells and benign thyroid conditions. A HNF-1 binding site was identified in the NNMT basal promoter region. Mutations in this site decreased NNMT promoter activity in the HNF-1beta-positive BHP 2-7 cells, but not in the HNF-1beta-negative BHP 14-9 cells. HNF-1beta bound to the HNF-1 site specifically as a homodimer as determined by gel retardation assays with HNF-1beta-specific antibody. Cotransfection of a HNF-1beta expression plasmid increased NNMT promoter activity significantly in both HNF-1beta-positive and -negative thyroid cancer cell lines and Hep G2 liver cancer cells. Furthermore, transient expression of HNF-1beta in BHP 14-9 cells increased endogenous NNMT protein levels. In summary, HNF-1beta functions as a transcription activator for NNMT gene expression in some papillary thyroid cancer cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486044     DOI: 10.1210/me.2004-0215

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  28 in total

1.  Development of a Suicide Inhibition-Based Protein Labeling Strategy for Nicotinamide N-Methyltransferase.

Authors:  Sudeshna Sen; Santanu Mondal; Li Zheng; Ari J Salinger; Walter Fast; Eranthie Weerapana; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2019-04-05       Impact factor: 5.100

2.  Effect of orally administered phenethyl isothiocyanate on hepatic gene expression in rats.

Authors:  Urvi Telang; Marilyn E Morris
Journal:  Mol Nutr Food Res       Date:  2010-12       Impact factor: 5.914

3.  Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.

Authors:  Changxue Lu; Alok Mishra; Yuelin J Zhu; Paul Meltzer; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

Review 4.  New molecular insights into peripheral T cell lymphomas.

Authors:  Stefano A Pileri; Pier Paolo Piccaluga
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

5.  N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis.

Authors:  Hui-Chang Bi; Yu-Zhuo Pan; Jing-Xin Qiu; Kristopher W Krausz; Fei Li; Caroline H Johnson; Chang-Tao Jiang; Frank J Gonzalez; Ai-Ming Yu
Journal:  Carcinogenesis       Date:  2014-08-12       Impact factor: 4.944

6.  Nicotinamide N-methyltransferase: a potential biomarker for worse prognosis in gastric carcinoma.

Authors:  Chen Chen; Xin Wang; Xing Huang; Hongmei Yong; Jiajia Shen; Qi Tang; Jin Zhu; Jian Ni; Zhenqing Feng
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

Review 7.  Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme.

Authors:  Pavlos Pissios
Journal:  Trends Endocrinol Metab       Date:  2017-03-11       Impact factor: 12.015

8.  Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Andrea Califano; Maura Rossi; Katia Basso; Simonetta Zupo; Philip Went; Ulf Klein; Pier Luigi Zinzani; Michele Baccarani; Riccardo Dalla Favera; Stefano A Pileri
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

Review 9.  Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders.

Authors:  Bernadette Biondi; George J Kahaly; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-06-01       Impact factor: 19.871

10.  Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells.

Authors:  Mikio Tomida; Hideki Ohtake; Takashi Yokota; Yasuhito Kobayashi; Masafumi Kurosumi
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.